Hirofumi Suemori

Hirofumi Suemori

Auto-generated profile, based on publicly available information

Hirofumi Suemori

Department of Embryonic Stem Cell Research, Institute for Frontier Medical Sciences, Kyoto University, 53 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2012 in Nature Communications
Verified
Journal Article
Open access
PDF file
TMTakamichi Miyazaki
Takamichi Miyazaki
SFSugiko Futaki
Sugiko Futaki
HSHirofumi Suemori
Hirofumi Suemori
YTYukimasa Taniguchi
Yukimasa Taniguchi
MYMasashi Yamada
Masashi Yamada
EKEihachiro Kawase
Eihachiro Kawase
Human embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs) have the potential to provide an infinite source of tissues for regenerative medicine. Although defined xeno-free media have been developed, culture conditions for reliable propagation of hESCs still require considerable improvement. Here we show that recombinant E8 fragments of laminin isoforms (LM-E8s), which are the minimum fragments conferring integrin-binding activity, promote greater adhesion of hESCs and hiPSCs than do Matrigel and intact laminin isoforms. Furthermore, LM-E8s sustain long-term self-renewal of hESCs and hiPSCs in defined xeno-free media with dissociated cell passaging. We successfully maintained three hESC and two hiPSC lines on LM-E8s in three defined media for 10 passages. hESCs maintained high level expression of pluripotency markers, had a normal karyotype after 30 passages and could differentiate into all three germ layers. This culture system allows robust proliferation of hESCs and hiPSCs for therapeutic applications.

1 July 2006 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
HSHirofumi Suemori
Hirofumi Suemori
KYKentaro Yasuchika
Kentaro Yasuchika
KHKouichi Hasegawa
Kouichi Hasegawa
TFTsuyoshi Fujioka
Tsuyoshi Fujioka
NTNorihiro Tsuneyoshi
Norihiro Tsuneyoshi
NNNorio Nakatsuji
Norio Nakatsuji

21 April 2010 in Genes to Cells
Verified
Journal Article
Closed access
PDF file
KAKeiko Adachi
Keiko Adachi
HSHirofumi Suemori
Hirofumi Suemori
SYShin‐Ya Yasuda
Shin‐Ya Yasuda
NNNorio Nakatsuji
Norio Nakatsuji
EKEihachiro Kawase
Eihachiro Kawase

17 November 2015 in Scientific Reports
Verified
Journal Article
Open access
SKShuhei Konagaya
Shuhei Konagaya
TATakeshi Ando
Takeshi Ando
TYToshiaki Yamauchi
Toshiaki Yamauchi
HSHirofumi Suemori
Hirofumi Suemori
HIHiroo Iwata
Hiroo Iwata
Pluripotent stem cells, such as embryonic stem cells and induced pluripotent stem (iPS) cells, are regarded as new sources for cell replacement therapy. These cells can unlimitedly expand under undifferentiated conditions and be differentiated into multiple cell types. Automated culture systems enable the large-scale production of cells. In addition to reducing the time and effort of researchers, an automated culture system improves the reproducibility of cell cultures. In the present study, we newly designed a fully automated cell culture system for human iPS maintenance. Using an automated culture system, hiPS cells maintained their undifferentiated state for 60 days. Automatically prepared hiPS cells had a potency of differentiation into three germ layer cells including dopaminergic neurons and pancreatic cells.

1 April 2000 in Developmental Biology
Verified
Journal Article
Closed access
HSHirofumi Suemori
Hirofumi Suemori
SNShigeru Noguchi
Shigeru Noguchi

1 December 2004 in The International Journal of Developmental Biology
Verified
Journal Article
Closed access
PDF file
TFTsuyoshi Fujioka
Tsuyoshi Fujioka
KYKentaro Yasuchika
Kentaro Yasuchika
YNYukio Nakamura
Yukio Nakamura
NNNorio Nakatsuji
Norio Nakatsuji
HSHirofumi Suemori
Hirofumi Suemori
Human embryonic stem (ES) cells have the potential to differentiate into all cell types. As these cells may be able to provide an unlimited cell source for transplantation therapies, it is necessary to establish reliable methods for their handling and manipulation, including human ES cell cryopreservation. Here, we report the development of a simple and efficient cryopreservation method for primate ES cell lines using vitrification in conventional cryovials. Using standard slow-rate cooling methods, the cryopreservation efficiency for cynomolgus monkey ES cell lines was approximately 0.4%, while that for a human ES cell line was virtually 0%. Primate ES cell lines, however, were successfully cryopreserved by the present vitrification method using conventional cryovials yielding a survival rate of about 6.5% for monkey ES cells and 12.2% for human ES cells. Vitrified ES cells quickly recovered after thawing and exhibited a morphology indistinguishable from non-vitrified cells. In addition, they retained a normal karyotype and continued to express ES cell markers after thawing. Thus, our vitrification ES cell cryopreservation method expands the utility of primate ES cells for various research and clinical purposes.